AUTL
Autolus Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$2.24
−2.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.97x
- Price / sales
- 5.08x
- Price / cash flow
- -2.64x
Enterprise value
- Enterprise value
- $478.1M
- EV / sales
- 4.07x
- EV / EBITDA
- -2.16x
- EV / EBIT
- -1.93x
- Market cap
- $596.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026